Between 2025 - 2026, the NHSCFA received a total of 8,048 reports alleging fraud, bribery, and corruption against the NHS in England. This is a significant increase when compared with the 6,764 reports received between 2024 - 2025.
| Financial year | 2020 - 2021 | 2021 - 2022 | 2022 - 2023 | 2023 - 2024 | 2024 - 2025 | 2025 - 2026 |
|---|---|---|---|---|---|---|
| Number of reports | 4,523 | 5,814 | 4,971 | 6,562 | 6,764 | 8,048 |
There was an increase of 1,284 reports compared with 2024 - 2025. It is possible that this increase is linked to Artificial Intelligence (AI), as individuals may not have heard of the NHSCFA prior to this year and when searching for ‘who to report an NHS crime to’, the NHSCFA can be the first suggestion and also the first website on the list of results. Additionally, some reports received by the NHSCFA are believed to have been written by AI or with the assistance of AI. This does not mean the initial incident did not occur, but that AI has been involved in the drafting of the report instead of entirely organic intelligence.
Top four reported areas
Reporting has increased by almost 19% when compared with 2024 - 2025, an increase in all but three thematic areas: GP contractor fraud, data manipulation and NHS bursary fraud. Of the 8,048 reports received in 2025 - 2026 approximately 84% related to the top four thematic areas of NHS staff fraud, patient exemption fraud, procurement and commissioning fraud, and fraudulent access to NHS care from overseas visitors.
There is often a robust hypothesis behind high or increased reporting levels, for example staff fraud is more visible than other types of fraud and patient exemption fraud carries a high volume of patient interactions. If patient exemption fraud is further examined it can be assessed that economic pressures and increasing NHS charges may further increase both deliberate evasion of charges and potential error, driving higher levels of information reports to the NHSCFA. The onward trade of prescription medication for personal gain was the highest reported MO within patient exemption fraud and coincides with the emergence of GLP-1 antagonist receptor weight-loss medications being prescribable via the NHS, like Mounjaro and Wegovy.